A majority of CGD patients carry pathogenic genotypes in one of five genes encoding subunits of the phagocyte NADPH oxidase; either X-linked recessive mutations in CYBB, or autosomal recessive mutations in CYBA, NCF1, NCF2, or NCF42,4–6. The gene discussed is FMO5; the disease is chronic granulomatous disease.